AI Analysis AI Analysis of ELTP AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add ELTP to Watchlist?
Some Reasons Why To Add ELTP:
  • Strong operating margin of 35.7%
  • Healthy interest coverage ratio of 98.1x
  • Strong return on equity of 71.4%
PDF

Elite Pharmaceuticals Inc stock upgraded to Buy Candidate
(Updated on Jun 25, 2026)

Buy or Hold candidate since Jun 15, 2026 Gain 4.76%

The Elite Pharmaceuticals Inc stock price gained 4.08% on the last trading day (Thursday, 25th Jun 2026), rising from $0.370 to $0.385. During the last trading day the stock fluctuated 6.94% from a day low at $0.360 to a day high of $0.385. The price has risen in 6 of the last 10 days and is up by 8.76% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 75 thousand more shares were traded than the day before. In total, 168 thousand shares were bought and sold for approximately $64.68 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -2.30% during the next 3 months and, with a 90% probability hold a price between $0.316 and $0.423 at the end of this 3-month period.

ELTP Signals & Forecast

The Elite Pharmaceuticals Inc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $0.368 and $0.358. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday, June 12, 2026, and so far it has risen 13.51%. Further rise is indicated until a new top pivot has been found. Elite Pharmaceuticals Inc has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Elite Pharmaceuticals Inc stock

Elite Pharmaceuticals Inc finds support from accumulated volume at $0.370 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0250 between high and low, or 6.94%. For the last week, the stock has had daily average volatility of 4.59%.

Our recommended stop-loss: $0.369 (-4.12%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 8 days ago.)

Trading Expectations (ELTP) For The Upcoming Trading Day Of Friday 26th

For the upcoming trading day on Friday, 26th we expect Elite Pharmaceuticals Inc to open at $0.377, and during the day (based on 14 day Average True Range), to move between $0.374 and $0.396, which gives a possible trading interval of +/-$0.0219 (+/-5.86%) up or down from last closing price. If Elite Pharmaceuticals Inc takes out the full calculated possible swing range there will be an estimated 5.86% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.370 (3.79%) than the resistance at $0.400 (3.87%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Earnings coming up

Elite Pharmaceuticals Inc will release earnings AMC on Monday, June 29, 2026. We will update the financials statements for Elite Pharmaceuticals Inc, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 10.45% in the first trading day after earnings release.

Is Elite Pharmaceuticals Inc stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

Current score: 3.355 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 26, 2026 - $0.377 ( 2.16%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

ELTP Performance

Trading levels for ELTP

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.402 4.33%
R2 0.392 1.85%
R1 0.386 0.316%
Price 0.385
S1 0.367 -4.65%
S2 0.361 -6.18%
S3 0.352 -8.66%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.435 12.99%
R2 0.403 4.68%
R1 0.400 3.87%
Price 0.385
S1 0.370 -3.79%
S2 0.348 -9.74%
S3 0.342 -11.30%

FAQ

What is the symbol for Elite Pharmaceuticals Inc Stock and on which exchange is it traded?
The symbol for Elite Pharmaceuticals Inc is ELTP and it is traded on the OTCMKTS (OTC Markets Group).

Should I buy or sell Elite Pharmaceuticals Inc Stock?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

How to buy Elite Pharmaceuticals Inc Stock?
Elite Pharmaceuticals Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Elite Pharmaceuticals Inc Stock.

What's the current price of Elite Pharmaceuticals Inc Stock?
As of the end of day on the Jun 25, 2026, the price of an Elite Pharmaceuticals Inc (ELTP) share was $0.385.

What is the 52-week high and low for Elite Pharmaceuticals Inc Stock?
The 52-week high for Elite Pharmaceuticals Inc Stock is $0.791 and the 52-week low is $0.325.

What is the market capitalization of Elite Pharmaceuticals Inc Stock?
As of the Jun 25, 2026, the market capitalization of Elite Pharmaceuticals Inc is 414.644M.

When is the next earnings date for Elite Pharmaceuticals Inc?
The upcoming earnings date for Elite Pharmaceuticals Inc is Jun 29, 2026.
Click to get the best stock tips daily for free!
ABOUT ELITE PHARMACEUTICALS INC
Elite Pharmaceuticals
Elite Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and manufacture of oral, controlled-release products and generic pharmaceuticals. The company operates in two segments, Abbreviated New Drug Applications for Generic Products and New Drug Applications for Branded Products. It owns, licenses, and contract manufactures various generic and oral dose pharmaceuticals products, such as Phentermine HCl 37.5mg tab...
GOLDEN STAR
Ticker Change Signal Date
NESR
$25.07
7.62% Jun 23
TTEK
$28.04
1.43% Jun 23
IDYA
$28.98
25.22% Jun 12
PHM
$118.49
14.53% Jun 10
DHI
$146.71
13.50% Jun 10

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE